AgeX Therapeutics(AGE) - 2024 Q1 - Quarterly Results
AgeX Therapeutics(AGE)2024-05-15 04:25
Exhibit 99.1 Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights HUNTSVILLE, May 14, 2024 (GLOBE NEWSWIRE) — Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery technology, today reported financial results for the quarter ended March 31, 2024 and provided business highlights. Recent Highlights ● Advancement of SER-252. The Company is advancing its lead drug candidate, ...